„Problemy z zasypianiem” – referencje

1. Malhowald, M.W., Kader, G., and Schenk, C.H. (1957). Clinical categories of sleep disorders I. Continuum 3(4): 35-65

2. NIH Consenss Development Conference Summary (1984). Drugs and insomnia: the use of medication to promote sleep. JAMA 251 (18): 2410-2414.

3.  Stoller, M.K. (1994). Economic effects of insomnia. Clin. Ter. 16 (5): 873-897.

4.  Vgontzas AN, Chrousos GP (2002), Sleep, the hypothalamic-pituitary-adresnal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am., 31: 15-36.

5.  Hrayr A.P. (2004), Epidemiology of Insomnia. In Clinical Handbook of Insomnia (Hrayr P. Attarian, ed), Humana Press, pp 11-21.

6.  Bonnet, M.H. and Arrand D.L. (2004), Physiological Basis of Insomnia. In Clinical Handbook of Insomnia (Hrayr P. Attarian, ed), Humana Press, pp 23-38.

7.  Monroe, L.J. (1967), Psychological and physiological differences between good and poor sleepers. Journal of Abnormal Psychology, 72: 255-264.

8.  Haynes, S.N., Follingstad, D.L., and McGowen, W.T. (1974). Insomnia: Sleep patterns and anxiety level. Journal of Psychosomatic Research, 18: 69-84.

9.  Freedman, R.R. and Sattler H.L. (1982). Physiological and psychological factors in sleep-onset insomnia. Journal of Abnormal Psychology, 91: 380-389.

10.  Freedman, R.R. (1986). EEG power spectra in sleep-onset insomnia. Electroenephal. Clin. Neurophysiol., 63: 408-413.

11.  Haynes, N.S., Adams, A. and Franzen, M. (1981). The effects of pre-sleep stress on sleep-onset insomnia. Journal of Abnormal Psychology, 90: 601-606.

12.  Bonnet, M.H. and Arand, D.L. (1988). Heart rate variability in insomniacs and matched normal sleepers. Psychosomatic Medicine, 60: 610-615.

13.  John, M.W., Gay, T.J.A., Masterton, J.P. and Bruce, D.Q. (1971). Relationship between sleep habits, adrenocortical activity and personality. Psychosomatic Medicine, 33: 499-508.

14. Mendelson, W.B., Garnett, D., Gillin, C.G., and Weingarner, H. (1984). The experience of insomnia and daytime and nighttime functioning. Psychiatric Research, 12: 235-250.

15.  Lamarche, CH., Ogilvie, RD., (1997). Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers. Sleep, 20: 724-733.

16.  Bonnet, MH, Arand, DL. (2000). Activity, arousal and the MSLT in patients with insomnia. Sleep, 23: 205-212.

17.  Hall, M., Buisse, D.J., Norwell, P.D., Nofzinger, E.A., Houck, P., Reynolds, C.F. et al. (2000). Symptoms of stress and depression as correlates of sleep in primary insomnia. Psychosom Med. 62: 227-230.

18.  Perlis, M.L., Kehl, E.L., Smith, M.T., Andrews, P.J., Orff, H., Giles, D.E. (2001). Temporal and stagewise distribution of high frequency EEG activity in patients with primary and secondary insomnia and in good sleeper controls. J. Sleep Res. 10: 93-104.

19.  Kirkwood C.K. (1999). Management of insomnia. J. Am. Pharm. Association, 39: 688-696.

20.  Wysowski, D.K., Baum, C. (1991). Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch. Intern. Med. 151: 1779-1783.

21.  Walsh, J.K., Schweitzer, P.K. (1999). Ten year trends in the pharmacological treatment of insomnia. Sleep, 22:371-375.

22.  Morin, C.M., Wooten, V. (1996). Psychological and pharmacological approaches to treating insomnia. Critical issues in assessing their separate and combined effects. Clinical Psychology Review, 16: 521-542.

23.  Nowell, P.D., Buysee, D.J., Morin, C.M., Reynolds, C.F. Effective treatments for effective sleep disorders. In: Nathan P.E., Gorman J.M. editors. A guide to treatment that work. New York, NY: Oxford University Press: 1998. Pg 531-543.

24.  Holbrook, A.M., Corwter, R., Lotter, A., Cheng, C., King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ, 162: 225-233.

25.  Gillin, J.C., Byerley, W.F. (1990). Drug therapy: The diagnosis and management of insomnia. New England Journal of Medicine, 322: 239-248.

26.  Gillin, J.C. (1991). The long and the short of sleeping pills. New England Journal of Medicine, 324: 1735-1736.

27.  Costa e Silva, J.A. (1999). Forward (to reports from the International Consensus Conference of Insomnia 10.11.96, Paris), Sleep, 22: S416.

28.  Soldatos, C.R., Dikeos, D.G., Whitehead, A. (1999). Tolerance and rebound insomnia with rapid eliminating hypnotics: a meta-analysis of sleep laboratory studies. International Clinical Prychopharmacol. 14: 287-303.

29.  Hajak, G., Clarenbach, P., Fisher, W., Rodenbeck, A., Bandelow, B., Broocks, A. et al. (1998). Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur. Arch. Psychiatry Clinical Neuroscience, 248: 148-156.

30.  Lader, M. (1998). Withdrawal reactions after stopping hypnotics in patients with insomnia. CNS Drugs, 10: 425-440.

31.  Espie, C.A., Linsday, W.R., Brooks, D.N. (1988). Substituting behavioral treatment for drugs in the treatment in the treatment of insomnia: an exploratory study. Journal of Behav Therp. Experimental Psychiatry, 19: 51-56.

32.  Lichstein, K.L., Riedel, B.W. (1988). Behavioral assessment and treatment of insomnia: A review with an emphasis on clinical application. Bahvioral Therapy, 25: 659-688.

33.  Sanavio, E. (1988). Pre-sleep cognitive intrusions and treatment of onset-insomnia. Behavioral Res. Therapy, 26: 451-459.

34.  Sanavio, E., Vidotto, G., Bettinardi, O., Rolletto, T., Zorzi, M. (1990). Behavior therapy for DIMS: Comparison of three treatment procedures with follow-up. Behavioral Psychotherapy, 18: 151-167.

35.  Bootzin, R.R., Rider, S.P. Behavioral techniques and biofeedback for insomnia, In: Pressman M.R., editor: Understanding sleep: The evaluation and treatment of sleep disorders. Application and practice in health psychology.Washington DC, American Psychological Association, 1997, p. 315-338.

36.  Morin, C.M., Hauri, P.J., Espie, C.A., Spielman, A.J., Buysse, D.J., Bootzin, R.R. (1999). Non-pharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep, 22: 1134-1156.

37.  Chesson, A.L.J., Anderson, W.M., Littner, M., Davila, D., Hartse, K., Johnson, S. et al. (1999). Practice parameters for the non-pharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of practice Committee of the American Academy of Sleep Medicine. Sleep, 22: 1128-1133.

38.  Spielman, A.J., Saskin, P., Thorpy, M.J. (1987). Treatment of chronic insomnia by restriction of time in bed. Sleep, 10: 45-56.

39.  Bliwise, D.L., Friedman, L., Nekich, J.C., Yesavage, J.A. (1995). Prediction of outcome in behaviorally based insomnia treatments. Journal of Behavioral Therapy Experimental Psychiatry, 26: 17-23.

40.  Morin, C.M., Azrin, N.H. (1987). Stimulus control and imagery training in treating sleep-maintenance insomnia. Journal Consult. Clinical Psychology, 55: 260-262.

41.  Woolfolk, R.L., McNulty, T.F. (1983). Relaxation treatment for insomnia: a component analysis. Journal Consult. Clinical Psychology, 51: 495-503.

42.  Morin, C.M., Azrin, N.H. (1988). Behavioral and cognitive treatments of geriatric insomnia. Journal Consult. Clinical Psychology, 56: 738-753.

43.  Stanton, H.E. (1989). Hypnotic relaxation and the reduction of sleep onset insomnia. International Journal of Psychosomatics, 36: 64-68.

44.  Nicassio, P., Bootzin, R. (1974). A comparison of progressive relaxation and autogenic training as treatment of insomnia. Journal of Abnormal Psychology, 83: 253-260.

45.  Kahn, M., Baker, B.L., Weiss, J.M. (1968). Treatment of insomnia by relaxation training. Journal of Abnormal Psychology, 73: 556-558.

46.  Sanavio, E. (1998). Pre-sleep cognitive intrusions and treatment of onset-insomnia. Behav. Res. Ther., 26: 451-459.

47.  Sanavio, E., Vidotto, G., Bettinardi, O., Rolletto, T., Zorzi, M. (1990). Behavior therapy for DIMS: Comparison for three treatment procedures with follow-up. Behavioral Psychotherapy, 18: 151-167.

48.  Tafet, G.E., Bernardini, R. (2003). Psycho-neuro-endocrinological links between chronic stress and depression. Progress in Neuro-Psychopharmacol. Biol. Psychiatry, 27: 893-903.

49.  Glaser, R. (2005). Stress associated immune dysregulation and its importance for human health: a personal history of psychoneuroimmunology. Brain Behav. Immun. 19: 3-11.

50.  Lupien, S.J., Fiocco, A., Wan, N., Maheu, F., Lord, C., Schramek, T. et al. (2005). Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology, 30: 225-242.

51.  McEwen, B.S., Stellar, E. (1993). Stress and the individual mechanisms leading to disease. Arch. Intern. Med. 153: 2093-20101.

18 maja 2018